Biopharmaceutical drugs are transforming the way we treat patients, fighting global diseases such as cancer and inflammatory diseases such as arthritis. Many pharmaceutical companies are expanding their biopharmaceutical capability, which is creating demand for talented, well-trained people. Designed, developed and delivered in partnership with Labcorp Drug Development (formerly known as Covance), a major multinational contract research company focused on drug development , this masters provides a springboard for high-quality life science graduates wanting to start a career in this industry. Due to exponential growth in the biopharmaceutical industry but a lack of suitable candidates, a skills gap currently exists which employers are desperate to fill. The course content focuses on the discovery and development of large molecule drugs: monoclonal antibodies like bio-similars, antibody-drug conjugates and gene therapies. Added to this is practical hands-on training in the technologies that underpin the discovery and development pathway. You’ll receive training in protein purification, characterisation, formulation and assessment of binding function and the use of cell-based assays to look at drug potency.
Modules
- Drug Discovery and Development Pathways
- Commercialising pharmaceutical products
- Biopharmaceutical Drug Discovery and Non-clinical testing
- Manufacturing Biopharmaceuticals
- Biopharmaceutical Development: Clinical
- Integrated Drug Development Plan
- Practical Skills for a Regulatory Environment
- Research Project
Add a Comment